000 | 01839 a2200553 4500 | ||
---|---|---|---|
005 | 20250517113226.0 | ||
264 | 0 | _c20180517 | |
008 | 201805s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/srep32585 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJin, Xi | |
245 | 0 | 0 |
_aA Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients. _h[electronic resource] |
260 |
_bScientific reports _c08 2016 |
||
300 |
_a32585 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAxilla _xpathology |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aChemotherapy, Adjuvant _xmethods |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 |
_aEpirubicin _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKi-67 Antigen _xgenetics |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 |
_aLymph Nodes _xdrug effects |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoadjuvant Therapy |
650 | 0 | 4 | _aNomograms |
650 | 0 | 4 |
_aPaclitaxel _xtherapeutic use |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aROC Curve |
650 | 0 | 4 |
_aReceptor, ErbB-2 _xgenetics |
650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
650 | 0 | 4 |
_aReceptors, Progesterone _xgenetics |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aSentinel Lymph Node Biopsy _xstatistics & numerical data |
650 | 0 | 4 |
_aTrastuzumab _xtherapeutic use |
650 | 0 | 4 | _aTumor Burden |
700 | 1 | _aJiang, Yi-Zhou | |
700 | 1 | _aChen, Sheng | |
700 | 1 | _aShao, Zhi-Ming | |
700 | 1 | _aDi, Gen-Hong | |
773 | 0 |
_tScientific reports _gvol. 6 _gp. 32585 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep32585 _zAvailable from publisher's website |
999 |
_c26374199 _d26374199 |